No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients-think empirical treatment

Crit Care. 2020 Sep 29;24(1):588. doi: 10.1186/s13054-020-03307-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • China
  • Coronavirus Infections*
  • Critical Illness
  • Humans
  • Invasive Pulmonary Aspergillosis*
  • Pandemics*
  • Pneumonia, Viral*
  • Retrospective Studies
  • SARS-CoV-2